Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Ligand (LGND) Breakout! -- Ignore unavailable to you. Want to Upgrade?

To: Hippieslayer who wrote (14616)	2/11/1998 4:27:00 PM
From: Alper H.YUKSEL	Read Replies (4) \| Respond to of 32384

<< People better understand companies when they show that they are making money. Also, many investors are probably scared to invest in a company that lives or dies by trials. There aren't many who have the stomach to invest in a volatile biotech company. Once LGND shows that their science translated into products that make them money, then maybe the squeamish will invest their money. Until then, they'll invest their money in a KO, T, or IBM where they know there money is safer than investing it in a biotech. >> That's certainly true. However, once companies show that they are making money, i.e. when the risk dimension has gotten smaller, so has most of the upside potential. It all depends on the risk/reward appetite of the individual investor. BTW, LGND up 1.90% for the day Alper

To: Hippieslayer who wrote (14616)	2/11/1998 4:30:00 PM
From: Torben Noerup Nielsen	Read Replies (2) \| Respond to of 32384

>Once LGND shows that their science translated into products that make >them money, then maybe the squeamish will invest their money. Until >then, they'll invest their money in a KO, T, or IBM where they know >there money is safer than investing it in a biotech. But a lot of investors aren't squeamish. They are interested in high potential returns. And it is those who invest in securities like LGND and LGNDW. I sense a certain disappointment with todays results. Although I would have liked to see more of a movement, I liked what I saw. Volume was decent on a generally slow day and the price did inch up a fraction for both the underlying and the warrants. Of course I would like to see a half on the underlying tomorrow, but I can wait a little while. Now if I could have an average of 1/8 per week for the next 6 months or so, I would be quite content :-) What everyone needs to focus on is the technology behind all of this. And as far as I can tell, it is solid and there are quite a few related compounds coming up. I just want to see the NDA for the Panretin gel get turned in. I believe management has stated that it is on schedule for Q1 which should be within the next month and a half. Cheers, Torben

To: Hippieslayer who wrote (14616)	2/11/1998 5:11:00 PM
From: Flagrante Delictu	Respond to of 32384

FUGAZI,>>Until then, they'll invest their money in a KO, T, or IBM, where they know their money is safer than investing in a biotech.<< The unfortunate truth is that the public probably thinks this statement is true. Those on this thread know that KO,T, & IBM are substantially up off their lows & the bios are substantially down from their highs. This is an ideal setup to wrest the public's money from it, as it seeks to fight the last battle instead of the forthcoming one. The public has been told by the putative gurus that they must own stocks with growing earnings. In general, the public probably doesn't understand that the reason bios don't generally have earnings is that they are not allowed to sell their products until they negotiate the hurdles set up for them by the FDA. The public is probably tired of quarter after quarter of negative e.p. s. from the bios, not understanding that there will probably be earnings, if not substantial earnings, once they are allowed to enter the marketplace. It is expected of the public that it abandon long held positions prior to their emergence from squalor & their vault to preeminence. It is also not unusual for the public to buy stocks that have run up far enough & long enough that the public can no longer "risk not owning them". Pity them. They are primed to enable the transfer of their assets "to their rightful owners" as the better informed like to think of themselves .Bernie.